概括
抗脂综合征 (APS) 增加了静脉血栓塞栓症和其他并发症的风险,在全关节或膝盖置换后. 对于这些患者,建议实施特定的抗凝血方案和术前风险评估.
科学领域:
- 整形外科 整形外科 整形外科
- 自免疫性疾病 自免疫性疾病
- 血管外科 血管外科
背景情况:
- 抗脂综合征 (APS) 是一种自身免疫性疾病,与静脉血栓塞栓症 (VTE) 的风险增加有关.
- 关节重建手术后APS对VTE风险的影响尚不清楚.
- 了解这些风险对于患者的管理和结果至关重要.
研究的目的:
- 为了研究抗脂综合征 (APS) 和整体关节整形术 (THA) 和全膝关节整形术 (TKA) 后的术后并发症之间的关联.
- 为了比较患有和没有APS接受THA或TKA的患者的深静脉血栓,肺栓塞和其他并发症的发生率.
- 在重大骨科手术的背景下,识别与APS相关的特定风险.
主要方法:
- 一个回顾性队列研究,利用TrinetX电子健康记录数据库.
- 对442,494名接受全关节整形手术 (THA) 或全膝关节整形手术 (TKA) 的患者进行分析.
- 倾向性得分匹配 (1:1比) 用于控制先前存在的APS和没有APS的患者之间的并发症.
主要成果:
- 在THA和TKA治疗后,患有APS的患者表现出明显更高的深静脉血栓形成率 (部:9.2%与6.0%;膝盖:10.5%与4.1%) 和肺栓塞率 (部:6.9%与3.6%;膝盖:8.4%与3.0%).
- 在APS患者中观察到贫血率增加 (部:24.8%与18.6%;膝盖:18.5%与13.9%).
- 在THA后,APS也与尿路感染和肺炎的发病率较高有关,但没有影响手术并发症或修复率.
结论:
- 抗脂综合征 (APS) 是术后并发症的重要危险因素,包括VTE和感染,在全关节和膝关节关节整形术后.
- 这些发现强调,需要针对性地制定抗凝策略,并对接受关节置换的APS患者进行彻底的手术前风险分层.
- 积极的管理可能会减轻这种患者群体中不良事件的风险增加.
更多相关视频
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
2.6K
09:31Individualized Stem-positioning in Calcar-guided Short-stem Total Hip Arthroplasty
Published on: February 27, 2018
11.8K
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
166
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
166
Disorders of Hemostasis
831
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
831
